Clinical Trials


Name of TrialDescription

RISE R-3750

A single and repeat dosing study to characterize the safety and tolerability of R-3750 orally delivered to patients with mild to moderate Ulcerative Colitis (UC).

MK-7240 (001-UC or 008-CD)

A phase three study to evaluate the safety and tolerability of MK-7240 for patients who have moderate to severely active ulcerative colitis (UC) or Crohn’s disease (CD).

Please contact Keanna Capener for more information:
Email: keanna.capener@cuanschutz.edu
Phone: 303-724-4420

Division of Gastroenterology and Hepatology

CU Anschutz

Academic Office One

12631 East 17th Avenue

B158

Aurora, CO 80045


CU Anschutz

Anschutz Outpatient Pavilion

1635 North Aurora Court

Aurora, CO 80045


CMS Login